Carbapenemase Gene Transmission in CREC

Carbapenem-resistant Enterobacter cloacae complex is an important but comparatively undercharacterized component of the broader carbapenem-resistant Enterobacteriaceae threat. The reference study by Chen and colleagues moves beyond simple resistance prevalence by examining where carbapenemase-encoding genes reside, whether they can transfer between bacteria, which mobile genetic elements accompany them, and how resistant isolates are related epidemiologically. This combination is valuable because resistance risk depends not only on the presence of a gene, but also on its genetic location and ability to disseminate.

Study Background and Research Question

Carbapenemase-encoding genes can hydrolyze carbapenem antibiotics and may contribute to resistance against multiple additional drug classes. In E. cloacae, these genes may be carried on chromosomes, plasmids, or both. Chromosomal carriage can stabilize resistance within a lineage, whereas plasmid carriage can facilitate horizontal gene transfer between bacterial cells. The distinction is therefore central to infection-control interpretation.

The study addressed a timely question: what are the genetic, phenotypic, and epidemiological characteristics of carbapenemase-encoding genes in carbapenem-resistant E. cloacae collected during the period shaped by the COVID-19 pandemic? The investigators analyzed 54 isolates obtained from eight teaching hospitals in Guangdong Province between December 2022 and June 2024, as reported in the reference study. The pandemic is relevant as a healthcare context because changes in antibiotic exposure, patient acuity, and service organization may alter the selection and transmission environment; however, the study primarily provides a contemporary surveillance snapshot rather than a formal pre-pandemic comparison.

Key Innovation from the Reference Study

The main innovation is the integration of four analytical levels in one CREC collection. First, the authors identified carbapenemase-encoding genes by PCR. Second, they used variable-temperature sodium dodecyl sulfate plasmid elimination to infer whether genes were plasmid-associated, chromosomal, or present in both locations. Third, conjugation experiments tested whether these genes could move into a recipient strain. Finally, ERIC-PCR and NTSYS analysis assessed the relatedness of the 54 isolates.

This design separates three concepts that are often conflated: gene carriage, gene location, and gene transmission potential. A PCR-positive isolate is not automatically a demonstrated transmission source, and a plasmid-associated gene is not necessarily transferable under every biological condition. By combining localization and conjugation with strain typing, the study provides a more useful framework for interpreting resistance surveillance data.

The work also places mobile genetic elements in the analysis. Insertion sequences and related elements can influence the capture, mobilization, and expression of resistance genes. Their inclusion helps connect the observed phenotype to plausible genetic mechanisms rather than treating carbapenem resistance as an isolated laboratory trait.

Methods and Experimental Design Insights

The isolate panel was assembled from clinical specimens submitted across multiple hospitals and departments. The authors characterized carbapenemase-encoding genes using PCR and compared antimicrobial susceptibility between isolates with and without detected genes using broth microdilution. This phenotype–genotype comparison is important because it tests whether gene-positive isolates display a broader resistance profile than gene-negative CREC rather than assuming that relationship.

To investigate genetic location, the variable-temperature SDS plasmid elimination approach was paired with PCR. Loss of a plasmid-associated signal after treatment supports plasmid localization, while persistence of the signal is compatible with chromosomal carriage. Because plasmid curing can be incomplete and may affect bacterial fitness, this approach is best interpreted as a localization strategy that benefits from complementary sequencing or plasmid profiling.

Conjugation experiments provided a functional test of horizontal transfer. Following mating, PCR was used to determine whether recipient bacteria acquired the relevant carbapenemase-encoding gene. The investigators also examined six mobile genetic elements and applied ERIC-PCR fingerprinting with NTSYS software to group isolates into related genotypes.

Protocol Parameters

• Study-reported isolate set: 54 carbapenem-resistant E. cloacae isolates from eight teaching hospitals, collected from December 2022 through June 2024; these parameters are described in the published study.
• Gene detection: PCR was used to identify carbapenemase-encoding genes after plasmid-elimination testing. For replication, the full article should be consulted for primer sequences, cycling conditions, and interpretation criteria.
• Plasmid localization: Variable-temperature SDS treatment was used as an experimental perturbation before PCR. This should be treated as a localization assay, not as definitive proof of complete plasmid curing.
• Susceptibility testing: Broth microdilution compared gene-positive and gene-negative groups across several antimicrobial agents. The condensed report does not provide every MIC distribution, so workflow comparisons should use the full results tables.
• Transfer testing: Conjugation followed by PCR assessed acquisition of carbapenemase-encoding genes by recipients. A positive mating result demonstrates transfer under the assay conditions, not necessarily transmission in a hospital or host.
• Strain relatedness: ERIC-PCR and NTSYS clustering were used for epidemiological grouping. Whole-genome sequencing would provide higher-resolution confirmation when investigating suspected outbreaks.

Core Findings and Why They Matter

Carbapenemase-encoding genes were detected in 46 of 54 isolates, or 85.19%, according to the reference study. The dominant pattern involved bla_NDM-1. Eighteen isolates, representing 33.33% of the collection, carried bla_NDM-1 on both chromosomes and plasmids, while 25 isolates, or 46.30%, carried the gene exclusively on plasmids. Two isolates contained only plasmid-borne bla_IMP, and one carried plasmid-associated bla_NDM-1 together with bla_KPC-2.

These distributions matter because plasmid-associated bla_NDM-1 creates a plausible route for resistance to move across strain backgrounds. Dual chromosomal and plasmid carriage may provide both persistence within a lineage and opportunities for horizontal spread. The findings also show why reporting only the percentage of carbapenemase-positive isolates is insufficient: two isolates with the same gene may differ substantially in their dissemination potential.

The gene-positive group showed significantly higher resistance rates to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin than the gene-negative group, with statistical significance reported for these comparisons in the study. The result supports a multidrug-resistance phenotype associated with carbapenemase carriage. It does not mean that every gene-positive isolate has the same susceptibility pattern, nor does it replace isolate-specific MIC testing when treatment or infection-control decisions are being considered.

Functional transfer experiments were particularly notable. Carbapenemase-encoding genes transferred successfully in 44 of 46 eligible isolates, or 95.65%. The success rate was 42 of 44 for bla_NDM-1, 2 of 2 for bla_IMP, and 0 of 1 for bla_KPC-2, as reported by Chen et al. The small denominators for bla_IMP and bla_KPC-2 require caution, but the overall result indicates a high transfer capacity among the tested isolates, especially for bla_NDM-1.

Six mobile genetic elements were identified. ISEcp1 was the most prevalent, occurring in 47 of 54 isolates, or 87.04%, and 22 isolates, or 40.74%, carried four mobile-element types simultaneously. This pattern suggests that resistance genes were embedded in genetically active backgrounds rather than distributed as isolated markers. Still, the presence of an insertion sequence is mechanistic context, not direct proof that it caused a particular transfer event.

ERIC-PCR divided the collection into 17 genotypes. Types E and G were each found in 11 isolates, or 20.37%, and isolates belonging to these groups originated from different departments in five hospitals. Two type E isolates shared a Dice coefficient of 100%. These observations are compatible with both interdepartmental dissemination and repeated emergence in a genetically diverse population. They do not, by themselves, establish a single transmission chain because ERIC-PCR lacks the resolution of whole-genome epidemiology and the study did not report direct patient-to-patient links.

The clinical distribution also provides surveillance priorities. Detection was highest among male patients, older individuals, respiratory medicine cases, and sputum specimens, accounting for 35 of 54, 39 of 54, 11 of 54, and 18 of 54 isolates, respectively, according to the reference paper. These frequencies should guide sampling and hypothesis generation, not be interpreted as proof that sex, age, department, or specimen type independently causes carbapenemase carriage.

Comparison with Existing Internal Articles

The internal article Polymyxin B (sulfate): Mechanistic Frontiers and Strategic Applications approaches multidrug-resistant Gram-negative infection from the perspective of membrane disruption and host-response biology. That emphasis complements the reference study’s surveillance and transmission framework, but it does not add evidence about the prevalence, localization, or conjugative transfer of carbapenemase genes in CREC.

Similarly, Polymyxin B (sulfate) in Cell Assays focuses on assay planning, cell viability, and immune readouts. It is relevant when translating microbiological findings into controlled host–pathogen experiments, including a dendritic cell maturation assay, but the Chen study itself did not test polymyxin exposure, dendritic-cell responses, or treatment outcomes. Keeping those evidence streams separate prevents mechanistic plausibility from being mistaken for a result of the reference study.

Limitations and Transferability

The sample size was modest and restricted to eight teaching hospitals in one province. Hospital participation, specimen distribution, and clinical referral patterns may therefore influence the observed frequencies. The high gene-positive proportion should not automatically be generalized to all Chinese hospitals, community settings, or other geographical regions.

The study period describes contemporary isolates but does not constitute a controlled longitudinal analysis of pre-pandemic versus pandemic transmission. Without baseline collections, repeated sampling, or time-resolved patient data, the contribution of COVID-19-related healthcare changes remains a contextual interpretation rather than a measured causal effect.

Plasmid elimination and conjugation provide valuable functional evidence but have technical boundaries. Failure to cure a plasmid does not necessarily prove chromosomal integration, and successful transfer in vitro may depend on the selected donor, recipient, medium, mating conditions, and antibiotic selection. Likewise, ERIC-PCR can identify broad relatedness but cannot resolve small genetic differences as reliably as whole-genome sequencing. Complete plasmid sequencing, replicon typing, resistance-island analysis, and patient or environmental sampling would strengthen transmission inference.

Finally, the study associates carbapenemase carriage with higher resistance rates but does not establish that every resistance phenotype is caused by the detected gene. Porin changes, efflux, additional beta-lactamases, target alterations, and other accessory mechanisms may contribute. The most transferable conclusion is therefore that plasmid-associated bla_NDM-1 and mobile genetic elements represent important surveillance targets in CREC, not that one genetic mechanism explains all resistance.

Research Support Resources

Why this cross-domain matters, maturity, and limitations

Researchers extending this work into Gram-negative bacterial infection research may use complementary microbiology and host-response workflows to test how resistant isolates interact with antimicrobial or immune systems. Polymyxin B (sulfate) (SKU C3090) can support appropriately designed laboratory workflows involving susceptibility or membrane-disruption studies, a dendritic cell maturation assay, or sepsis and bacteremia models. Its description as an antibiotic for bloodstream and urinary tract infections should not be interpreted as evidence that it was effective against the CREC isolates in this paper; Chen et al. did not evaluate Polymyxin B treatment or polymyxin susceptibility. Use should remain limited to scientific research, with handling and storage based on the product documentation and institutional safety procedures.